Acadia Healthcare Q4 2024 Earnings Report
Key Takeaways
Acadia Healthcare's Q4 2024 revenue increased by 4.2% year-over-year to $774.2 million, driven by higher patient volumes and growth in same-facility revenue. However, net income declined to $32.6 million, impacted by increased operating expenses and facility-related costs. Adjusted EPS came in at $0.64, while adjusted EBITDA totaled $153.1 million, reflecting a $14.3 million professional liability reserve adjustment and a $5.0 million impact from facility closures.
Total revenue increased by 4.2% year-over-year to $774.2 million.
Same-facility revenue grew by 4.7%, driven by a 3.2% increase in patient days.
Net income declined to $32.6 million, impacted by higher costs and facility closures.
Adjusted EPS improved to $0.64, while adjusted EBITDA reached $153.1 million.
Acadia Healthcare Revenue
Acadia Healthcare EPS
Forward Guidance
Acadia Healthcare expects continued revenue growth in 2025, with stable margins and expansion in patient capacity.
Positive Outlook
- Full-year 2025 revenue projected between $3.3 billion and $3.4 billion.
- Adjusted EBITDA expected to be in the range of $675 million to $725 million.
- Adjusted EPS guidance set at $2.50 to $2.80.
- Expansion plans include adding 800 to 1,000 new beds.
- Continued investments in joint ventures and technology to drive growth.
Challenges Ahead
- Interest expense expected to increase to $130 million to $140 million.
- Depreciation and amortization expenses projected at $175 million to $185 million.
- Startup losses for newly opened facilities expected to rise to $50 million to $55 million.
- Potential net decrease in Medicaid supplemental payments of up to $15 million.
- Expansion capital expenditures projected to be between $525 million and $575 million.